The short answer
For men over 40 without symptoms, heart health assessment starts with blood pressure, cholesterol, smoking status, medical and family history, and glucose testing when indicated. The 2026 ACC/AHA dyslipidemia guideline also recommends measuring lipoprotein(a), or Lp(a), at least once in adulthood. ApoB testing and coronary calcium scans have more selective roles. Tests for symptoms answer a different question from screening someone who feels well.
Cardiovascular risk assessment is less about finding a single dramatic test and more about combining a few ordinary measurements well. This guide explains what each of the standard tests contributes, where each falls short, and why advanced imaging is not a routine first step for men without symptoms.
Key takeaways
- Cardiovascular assessment combines blood pressure, lipids, glucose, smoking and history into a risk estimate.
- The 2026 guideline recommends at least one adult Lp(a) measurement; apoB testing and calcium scans are more selective.
- Coronary calcium scoring is most useful when treatment decisions are genuinely uncertain.
- Symptoms during exertion call for evaluation rather than screening.
- Most achievable risk reduction comes from the fundamentals, applied consistently.
Risk is estimated, not measured
Clinicians estimate cardiovascular risk using validated equations that combine age, sex, blood pressure, cholesterol, diabetes status, smoking and treatment status. The output is a probability over a defined period, not a prediction about you specifically.
That estimate is what turns individual numbers into decisions. A cholesterol value means something different in a 45-year-old non-smoker with normal blood pressure than in a 55-year-old with diabetes and hypertension.
Risk-enhancing factors, such as a strong family history of premature heart disease, chronic inflammatory conditions or chronic kidney disease, can shift the conversation even when the calculated number sits in a middle band.
The 2026 ACC/AHA dyslipidemia guideline uses PREVENT-ASCVD estimates to guide prevention discussions in eligible adults aged 30 to 79. Ask which calculator and time horizon your clinician is using; risk categories from older calculators are not interchangeable with PREVENT categories.
What each test contributes
| Test | Purpose | Limitation |
|---|---|---|
| Blood pressure | Identifies hypertension, one of the strongest modifiable risk factors | Single clinic readings are unreliable; confirmation outside the clinic is often needed |
| Lipid panel | Measures cholesterol fractions and triglycerides for risk estimation | Does not by itself indicate whether plaque is present |
| A1C or fasting glucose | Screens for prediabetes and diabetes when indicated by age and risk | An abnormal screening result may need confirmation; age 40 alone does not set everyone's testing schedule |
| Lipoprotein(a), or Lp(a) | Identifies an inherited contributor to cardiovascular risk; the 2026 guideline recommends at least one adult measurement | It is a risk marker, not a scan for blocked arteries; repeat testing is generally unnecessary |
| Apolipoprotein B, or apoB | May clarify remaining lipid-related risk, especially with diabetes or high triglycerides | Used selectively, including when LDL-C and non-HDL-C goals have been reached |
| Coronary artery calcium score | Detects calcified plaque and can help resolve uncertainty about preventive treatment | Involves radiation, may not be covered by insurance, and is used selectively |
| Exercise ECG (a treadmill stress test) | Evaluates symptoms suggestive of coronary disease | USPSTF recommends against screening low-risk adults without symptoms; evidence is insufficient at intermediate or high risk |
| Resting ECG | Useful when symptoms, arrhythmia or specific findings are suspected | The same USPSTF screening limits apply: against screening at low risk, insufficient evidence at intermediate or high risk |
Where the biggest gains usually are
In practice, most of the achievable risk reduction comes from a short list: blood pressure control, not smoking, physical activity, managing blood glucose, treating high cholesterol when indicated, sleep and alcohol.
The American Heart Association groups these into a small set of measures precisely because the fundamentals account for so much of the difference between people at similar ages.
- Know your blood pressure pattern, not just one reading.
- Know your LDL cholesterol and whether treatment has been discussed.
- Ask whether glucose screening is due and bring any previous results.
- Know your estimated ten-year risk and what drives it.
- Know your family history of heart disease before age 55 in men or 65 in women.
When additional testing is reasonable
Under the 2026 ACC/AHA guideline, coronary artery calcium testing can help men aged 40 or older with borderline or intermediate risk when the result would change a decision about statin treatment. It is not an automatic scan for every man reaching 40.
For glucose screening, the USPSTF recommends testing adults aged 35 to 70 who have overweight or obesity, with earlier testing considered for some higher-risk groups. A1C and fasting glucose are options; they are not a required pair for everyone.
The USPSTF's 2018 ECG recommendation distinguishes low-risk adults without symptoms, for whom it recommends against screening, from those at intermediate or high risk, for whom evidence is insufficient. Insufficient evidence is not a recommendation to order a routine stress test.
Symptoms change the picture completely. Chest discomfort with exertion, unusual breathlessness, palpitations with dizziness or reduced exercise tolerance are reasons for evaluation, not for a screening discussion.
Commonly confused
“A normal stress test means my arteries are clear.”
Stress testing evaluates flow-limiting disease. Non-obstructive plaque can be present with a normal result.
“Everyone should get a calcium score.”
It can help selected people at borderline or intermediate risk when the result would change treatment. It is not a routine scan for all adults.
“Cholesterol is the only number that matters.”
Blood pressure, glucose, smoking, activity and family history all feed into risk, and treatment decisions weigh them together.
Questions to raise with a healthcare professional
- What is my estimated ten-year cardiovascular risk, and which factors drive it?
- Do I have risk-enhancing factors that change the interpretation?
- Would additional testing change what we do next?
- Have I had an Lp(a) measurement, and would an apoB result add useful information in my case?
- Is my blood pressure confirmed with readings outside the clinic?
- What would you like me to work on first?
When to seek care
Worth a routine appointment
- Repeated elevated blood pressure readings, or lipid or glucose results you have not discussed.
- Reduced exercise tolerance developing over weeks.
Seek help without delay
- Chest pain or pressure, pain spreading to the arm, neck or jaw, sudden severe breathlessness, fainting or sweating with chest discomfort. Call 911 in the United States.
References
- American Heart Association. Life's Essential 8: the key measures for improving cardiovascular health
- American Heart Association. 2026 Dyslipidemia Guideline: Top Things to Know
- American College of Cardiology. ACC/AHA Issue Updated Guideline for Managing Lipids, Cholesterol (2026)
- US Preventive Services Task Force. Cardiovascular Disease Risk: Screening With Electrocardiography (2018)
- US Preventive Services Task Force. Prediabetes and Type 2 Diabetes: Screening (2021)
- US Preventive Services Task Force. Hypertension in Adults: Screening (2021)
How this article is reviewed
Aldrick articles are written from published guidance and peer-reviewed research, checked against our evidence standards and re-reviewed when guidance changes. Spotted something inaccurate or out of date? Tell us and we will correct it and update the review date.
This article is educational. It does not diagnose conditions or replace evaluation by a qualified clinician.